 |
|
Visceral Leishmaniasis: Clinical Observations in 4 US Army Soldiers Deployed to Afghanistan or Iraq, 2002-2004
Otha Myles, MD;
Glenn W. Wortmann, MD;
James F. Cummings, MD;
R. Vincent Barthel, MD, MPH;
Sugat Patel, MD;
Nancy F. Crum-Cianflone, MD, MPH;
Nathan S. Negin, MD;
Peter J. Weina, MD, PhD;
Christian F. Ockenhouse, MD, PhD;
Daniel J. Joyce, DO;
Alan J. Magill, MD;
Naomi E. Aronson, MD;
Robert A. Gasser Jr, MD
Arch Intern Med. 2007;167(17):1899-1901.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
People who traveled to Central or Southwest Asia in support of Operation Enduring Freedom and Operation Iraqi Freedom may have been exposed to various diseases endemic to this region.1 Some of these conditions have long incubation periods and may not present for weeks or months after travelers have returned to the United States. Among such diseases is visceral leishmaniasis (VL). Visceral leishmaniasis is a chronic systemic disease caused by parasites of the Leishmania donovani–Leishmania infantum complex. It is classically described as a syndrome of fever, progressive spleen and/or liver enlargement, weight loss, pancytopenia, and, if . . . [Full Text of this Article]Methods
Results
Comment
AUTHOR INFORMATION
|
